https://www.live-feeds.com/feed/lsd-just-passed-its-biggest-test-yet-for-treating-depressionContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/lsd-just-passed-its-biggest-test-yet-for-treating-depressionhttps://www.live-feeds.com/feed/lsd-just-passed-its-biggest-test-yet-for-treating-depression#u14804Fri, 26 Jun 2026 21:42:30 +0000Definium Therapeutics reported positive topline results from the Phase 3 Emerge study for its DT120 orally disintegrating tablet. A single supervised dose of the LSD-based therapy significantly reduced symptoms in adults with major depressive disorder compared to a placebo. The drug demonstrated 12-week durability and met all primary and key secondary endpoints.What's confirmed:Definium Therapeutics' DT120 orally disintegrating tablet produced positive topline results in the Phase 3 Emerge study for major depressive disorder.The DT120 trial involved 149 patients and met all primary and ke